Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, south Italy

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 8, 2008, Pages 2002-2006

  Ammatuna, Pietro ^a   Giovannelli, Lucia ^a   Matranga, Domenica ^a   Ciriminna, Saverio ^b   Perino, Antonio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Ispettorato Regionale Sanità ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONDYLOMA ACUMINATUM; CYTOLOGY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 84; ITALY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEXUALITY; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; CHI-SQUARE DISTRIBUTION; FEMALE; GENOTYPE; HUMANS; ITALY; LOGISTIC MODELS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEXUALLY TRANSMITTED DISEASES, VIRAL; YOUNG ADULT;

EID: 54049155817     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0180     Document Type: Article

References (24)

1. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiologyof human cancer. Vaccine 2006;24S3:S1-10.
2. Trottier H, Franco EL. The epidemiologyof genital human papillomavirus infection. Vaccine 2006;24 Suppl 1:S1-15.
3. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-9.
4. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366:991-8.
5. Ames A, Gravitt P. Human papillomavirus vaccine update. Curr Infect Dis Rep 2007;9:151-8.
6. Ronco G, Ghisetti V, Segnan N, et al. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 2005;41:297-305.
7. Manhart LE, Holmes KK, Koutsky LA, et al. Human papillomavirus infection among sexually active young women in the United States: implications for developing a vaccination strategy. Sex Transm Dis 2006;33:502-8.
8. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004;324:17-27.
9. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
10. Gestione della paziente con il Pap-test anormale. Linee Guida Edizione 2006. La Colposcopia in Italia, Società Italiana di Colposcopia e Patologia Cervico Vaginale 2006;Anno XXI.
11. van Buuren S, Brand JPL, Groothuis-Oudshoorn K, Rubin DB. Fully conditional specification in multivariate imputation. J Stat Comput Simul 2006;76:1049-64.
12. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157:218-26.
13. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
14. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis 2002;186:462-9.
15. Shin HR, Franceschi S, Vaccarella S, et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 2004;190:468-76.
16. De Francesco MA, Gargiulo F, Schreiber C, Ciravolo G, Salinaro F, Manca N. Detection and genotyping of human papillomavirus in cervical samples from Italian patients. J Med Virol 2005;75:588-92.
17. Walter H, Matsumoto H, Danker-Hopfe H, De Stefano GF, Rickards O. GM and KM allotypes in nine population samples of Sicily. Ann Hum Biol 1997;24:419-26.
18. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285:2995-3002.
19. Moscicki AB, Palefsky J, Gonzales J, Schoolnik GK. Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors. Pediatr Res 1990;28:507-13.
20. Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 2006;24 Suppl 3:S42-51.
21. Karlsson R, Jonsson M, Edlund K, et al. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis 1995;22:119-27.
22. Vaccarella S, Herrero R, Dai M, et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006;15:2148-53.
23. Silins I, Kallings I, Dillner J. Correlates of the spread of human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2000;9:953-9.
24. Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics 2002;109:E5.